Loading clinical trials...
Loading clinical trials...
A Phase Ib, Open-Label, Multi-Centre Study to Assess the Safety, Tolerability, Pharmacokinetics, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours
Conditions
Interventions
AZD 1775
Locations
16
United States
Research Site
Fayetteville, Arkansas, United States
Research Site
San Francisco, California, United States
Research Site
West Hollywood, California, United States
Research Site
Fort Myers, Florida, United States
Research Site
Indianapolis, Indiana, United States
Research Site
Detroit, Michigan, United States
Start Date
July 1, 2015
Primary Completion Date
January 25, 2018
Completion Date
August 22, 2019
Last Updated
July 3, 2023
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions